Pylarify (piflufolastat f 18) injection for topeka VA medical center

Active Awarded Last action

Contract number
36C25526A0007
Awardee
Awarding agency
Task orders
1 $396,959 obligated

Award facts

Opportunity
  • 36C25526Q0009 Solicitation number
Combined order value
$396,959 Current and potential, with all options
Last date to order 49% complete
IDV ceiling 50% used
$793,918.40
Maximum order
$250,000.00
Award type
Single award
Who can order
Only the awarding agency
Contracting staff
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price

Award details come from SAM.gov/FPDS.

About this IDV

Progenics Pharmaceuticals Inc., a division of Lantheus Medical Imaging, Inc., has been awarded a single-award Blanket Purchase Agreement by Veterans Integrated Service Network 15 (VISN 15) for the supply of PYLARIFY (piflufolastat F-18) injection, a diagnostic radiopharmaceutical used in positional emission tomography (PET) imaging for prostate cancer detection and localization. The BPA has a ceiling value of $793,918.40 and runs through October 31, 2027, with performance occurring in North Billerica, Massachusetts. The contract operates under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) and is not designated as a set-aside procurement. As the primary federal supply schedule contract vehicle for this product line, the BPA enables VISN 15 and other VA medical centers nationwide to efficiently procure critical radiopharmaceutical imaging agents required for oncology diagnostic programs without requiring separate competitive solicitations for each order.

The associated task order funded under this BPA vehicle for ordering period one carries a ceiling value of $396,959.20, also awarded on November 1, 2025, with firm fixed-price terms through October 31, 2027. This procurement structure allows the Department of Veterans Affairs to maintain consistent access to PYLARIFY across multiple VA medical facilities while providing Progenics Pharmaceuticals with predictable demand for a specialized pharmaceutical product essential to prostate cancer imaging programs. The Blanket Purchase Agreement vehicle reflects the VA's strategic approach to securing critical, single-source radiopharmaceutical products that support medical imaging operations across the Veterans Integrated Service Network.

Task orders

Task order Ordering agency Obligated Awarded
Funding for ordering period one of 36C25526A0007 36C25526N0058 Veterans Integrated Service Network 15 (VHA) $396,959

Quick answers

Who was awarded contract 36C25526A0007?

36C25526A0007 was awarded to Progenics Pharmaceuticals Inc. by Veterans Integrated Service Network 15 (Veterans Health Administration) on November 1, 2025.

How much is contract 36C25526A0007 worth?

Orders under 36C25526A0007 have obligated $396,959. 36C25526A0007's own ceiling is $793,918. A single order can be worth up to $250,000.

How many orders have been placed under contract 36C25526A0007?

1 order has been placed under 36C25526A0007, the latest on November 1, 2025.

Who can order from contract 36C25526A0007?

36C25526A0007 is a single award blanket purchase agreement. Only the awarding agency can place orders on it.

Is contract 36C25526A0007 under another contract?

Yes. 36C25526A0007 is a blanket purchase agreement under 36F79725D0093, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).

Was contract 36C25526A0007 competed?

The extent of competition for 36C25526A0007 was full and open competition. The government received 1 offer.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV